Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series.
作者信息
Morecroft Renée, Phillipps Jordan, Barozinsky Kaiden, Jones Susan, Sun Lulu, Crites Danielle, Butt Omar, Ansstas George, Grierson Patrick, Johanns Tanner M, Zhou Alice
机构信息
Department of Internal Medicine, HCA Florida Orange Park Hospital, Orange Park, Florida.
Department of Dermatology, Mayo Clinic, Jacksonville, Florida.
出版信息
JAAD Case Rep. 2025 Jul 12;64:128-134. doi: 10.1016/j.jdcr.2025.04.047. eCollection 2025 Oct.
Abstract
摘要
相似文献
1
Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series.
JAAD Case Rep. 2025 Jul 12;64:128-134. doi: 10.1016/j.jdcr.2025.04.047. eCollection 2025 Oct.
2
Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Clin Cancer Res. 2014 Feb 1;20(3):764-75. doi: 10.1158/1078-0432.CCR-13-2287. Epub 2013 Nov 15.
3
Targeting CDK9 With Harmine Induces Homologous Recombination Deficiency and Synergizes With PARP Inhibitors in Ovarian Cancer.
Phytother Res. 2025 Aug;39(8):3648-3663. doi: 10.1002/ptr.70021. Epub 2025 Jul 9.
4
Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.
Genes Chromosomes Cancer. 2023 Dec;62(12):710-720. doi: 10.1002/gcc.23190. Epub 2023 Jul 12.
5
The Molecular Mechanisms of Actions, Effects, and Clinical Implications of PARP Inhibitors in Epithelial Ovarian Cancers: A Systematic Review.
Int J Mol Sci. 2022 Jul 23;23(15):8125. doi: 10.3390/ijms23158125.
6
Ovarian high-grade serous carcinoma with transitional-like (SET) morphology: a homologous recombination-deficient tumor.
Hum Pathol. 2023 Nov;141:15-21. doi: 10.1016/j.humpath.2023.08.010. Epub 2023 Sep 9.
7
Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities.
Int J Mol Sci. 2024 Apr 24;25(9):4624. doi: 10.3390/ijms25094624.
8
Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells.
J Cancer Res Clin Oncol. 2012 May;138(5):811-8. doi: 10.1007/s00432-011-1132-8. Epub 2012 Jan 25.
9
DNA Repair Gene Alterations and PARP Inhibitor Response in Patients With Metastatic Castration-Resistant Prostate Cancer.
J Natl Compr Canc Netw. 2018 Aug;16(8):933-937. doi: 10.6004/jnccn.2018.7020.
10
JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-Addiction.
Int J Biol Sci. 2025 Aug 22;21(12):5460-5475. doi: 10.7150/ijbs.113726. eCollection 2025.
本文引用的文献
1
Homologous Recombination Deficiency (HRD) in Cutaneous Oncology.
Int J Mol Sci. 2023 Jun 28;24(13):10771. doi: 10.3390/ijms241310771.
2
Targeting DNA damage response pathways in cancer.
Nat Rev Cancer. 2023 Feb;23(2):78-94. doi: 10.1038/s41568-022-00535-5. Epub 2022 Dec 5.
3
Diagnosis and Management of Porocarcinoma.
Cancers (Basel). 2022 Oct 25;14(21):5232. doi: 10.3390/cancers14215232.
4
Molecular pathology of skin adnexal tumours.
Histopathology. 2022 Jan;80(1):166-183. doi: 10.1111/his.14441.
5
Whole-exome sequencing in eccrine porocarcinoma indicates promising therapeutic strategies.
Cancer Gene Ther. 2022 Jun;29(6):697-708. doi: 10.1038/s41417-021-00347-z. Epub 2021 May 27.
6
Update on Molecular Genetic Alterations of Cutaneous Adnexal Neoplasms.
Surg Pathol Clin. 2021 Jun;14(2):251-272. doi: 10.1016/j.path.2021.03.004.
7
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001.
8
Germline Mutations in Cancers and Its Distinction From Somatic Mutations in Breast Cancers.
Front Genet. 2020 Aug 27;11:829. doi: 10.3389/fgene.2020.00829. eCollection 2020.
9
DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer.
J Gastrointest Oncol. 2019 Dec;10(6):1133-1139. doi: 10.21037/jgo.2019.09.12.
10
Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families.
J Clin Oncol. 2020 Mar 1;38(7):674-685. doi: 10.1200/JCO.19.01907. Epub 2019 Dec 16.
Zotero 插件